Semaglutide FAQ

Semaglutide is a peptide that belongs to a class of drugs called GLP-1 receptor agonists. It is approved by the FDA for the treatment of type 2 diabetes and has also been found to be effective in weight loss.

Studies have shown that semaglutide can lead to significant weight loss in individuals who are overweight or obese. In one study, participants who took semaglutide lost an average of 15% of their body weight over 68 weeks. This is a significant amount of weight loss, especially when compared to traditional weight loss methods.

Semaglutide works by mimicking the effects of a hormone called GLP-1, which is naturally produced in the body and helps to regulate blood sugar and appetite. Semaglutide also slows digestion, allowing you to feel fuller for longer.

Semaglutide is taken via a once-weekly injection.

The first and second months are $500/month. The 3rd month is $700 due to the increased dosages.

Every patient is different but most patients take this medication for 2-3 months.

The most common side effects are nausea, gastrointestinal distress, and heartburn.

Insurance companies typically do not cover this medication when it is prescribed for weight loss.